GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 94 filers reported holding GALENA BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $46,000 | -24.6% | 130,373 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $61,000 | -65.5% | 130,373 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $177,000 | -7.8% | 130,373 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $192,000 | -6.8% | 130,373 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $206,000 | -7.2% | 130,373 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $222,000 | +22.7% | 130,373 | 0.0% | 0.00% | +50.0% |
| Q1 2015 | $181,000 | -8.1% | 130,373 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $197,000 | -28.6% | 130,373 | -2.8% | 0.00% | -50.0% |
| Q3 2014 | $276,000 | -32.8% | 134,173 | 0.0% | 0.00% | -42.9% |
| Q2 2014 | $411,000 | +22.7% | 134,173 | 0.0% | 0.01% | +16.7% |
| Q1 2014 | $335,000 | – | 134,173 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 375,000 | $855,000 | 0.93% |
| HIGHLAND CAPITAL MANAGEMENT LP | 800,000 | $1,824,000 | 0.12% |
| Alyeska Investment Group, L.P. | 780,000 | $1,778,000 | 0.07% |
| KMS FINANCIAL SERVICES, INC | 119,500 | $272,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 539,150 | $1,229,000 | 0.04% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 25,100 | $57,000 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 349,400 | $793,000,000 | 0.02% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 12,000 | $27,000 | 0.02% |
| Diversified Trust Co | 40,000 | $91,000 | 0.01% |
| PITTENGER & ANDERSON INC | 18,000 | $41,000 | 0.01% |